Log in to save to my catalogue

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic...

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6353894

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer

About this item

Full title

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2019-02, Vol.120 (3), p.340-345

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
Metastatic colorectal cancer (mCRC) is a highly heterogeneous disease from a clinical, molecular, and immunological perspective. Current predictive models rely primarily in tissue based genetic analysis, which not always correlate with inflammatory response. Here we evaluated the role of a circulating inflammatory signature as a progn...

Alternative Titles

Full title

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6353894

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6353894

Other Identifiers

ISSN

0007-0920,1532-1827

E-ISSN

1532-1827

DOI

10.1038/s41416-018-0360-y

How to access this item